Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Contents
Current Cancer Drug Targets, Volume 15 - Number 6
Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
, 15(6): 452 - 462Saїd C. Azoury, David M. Straughan and Vivek Shukla
DOI: 10.2174/156800961506150805145120
Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas
, 15(6): 463 - 468Marc Giry-Laterriere, Andreia V. Pinho, Nils Eling, Lorraine Chantrill and Ilse Rooman
DOI: 10.2174/1568009615666150512102957
Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas
Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer
, 15(6): 469 - 480Lewis Quayle, Penelope D. Ottewell and Ingunn Holen
DOI: 10.2174/1568009615666150506092443
Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer
Extracellular Ca2+ Selectively Enhances Adriamycin-induced Cell Death in Human Hepatoma Cells
, 15(6): 481 - 492Xuexue Huang, Yuan Xu, Yanyi Liu, Hong Xie, Jiachun Wang and Zhigang Wu
DOI: 10.2174/156800961506150805151905
Extracellular Ca2+ Selectively Enhances Adriamycin-induced Cell Death in Human Hepatoma Cells
A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor
, 15(6): 493 - 503Yin Li, Kai Chen, Yong Zhou, Yiren Xiao, Manman Deng, Zhiwu Jiang, Wei Ye, Xiangmeng Wang, Xinru Wei, Jie Li, Jiabao Liang, Zhongxin Zheng, Yao Yao, Weiguang Wang, Peng Li and Bing Xu
DOI: 10.2174/156800961506150805153230
A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor
11-Phenylundeca-5Z,9Z-dienoic Acid: Stereoselective Synthesis and Dual Topoisomerase I/IIα Inhibition
, 15(6): 504 - 510Vladimir A. D’yakonov, Lilya U. Dzhemileva, Aleksey A. Makarov, Alfiya R. Mulyukova, Dmitry S. Baevd, Elza K. Khusnutdinova, Tatiana G. Tolstikova and Usein M. Dzhemilev
DOI: 10.2174/1568009615666150506093155
11-Phenylundeca-5Z,9Z-dienoic Acid: Stereoselective Synthesis and Dual Topoisomerase I/IIα Inhibition
The Prognosis of Patients with Liver Metastases from Colorectal Cancer still Depends on Anatomical Presentation more than on Treatments
, 15(6): 511 - 518Paolo G. Gobbi, Sandro Rossi, Mario Comelli, Valentina Ravetta, Laura L. Rosa, Silvia Brugnatelli, Franco Corbella, Sara Delfanti, Islam Abumalouh and Paolo Dionigi
DOI: 10.2174/1568009615666150508094824
The Prognosis of Patients with Liver Metastases from Colorectal Cancer still Depends on Anatomical Presentation more than on Treatments
CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription
, 15(6): 519 - 532Zanxian Xia, Mingquan Guo, Han Liu, Luwei Jiang, Qiaoxia Li, Jian Peng, Jia-Da Li, Baoen Shan, Pinghui Feng and Hong Ma
DOI: 10.2174/1568009615666150506093643
CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription
A novel NGR-conjugated peptide targets DNA damage responses for radiosensitization
, 15(6): 533 - 541Jinlu Ma, Dan Zhang, Xia Ying, Ying Zhao, Chenchen He, Qing Zhu and Suxia Han
DOI: 10.2174/1568009615666150408114817
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net